Market Research Logo

Chile Pharmaceuticals and Healthcare Report Q2 2016

BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Chile 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Chile 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Chile 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Chile 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Chile 2014-2020)
Industry Risk Reward Index
Americas Risk/Reward Index
Chile Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Public Procurement
Table: Pharmaceutical Price Build-Up (%)
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Chile 2009-2014)
Table: Healthcare Personnel (Chile 2009-2014)
Table: Healthcare Activity (2009-2014)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Corporación Farmacéutica Recalcine (CFR)
GlaxoSmithKline
Laboratorios Andrómaco
Laboratorios Chile (LabChile)
Merck & Co
Novartis
Pfizer
Sanofi
Demographic Forecast
Table: Population Headline Indicators (Chile 1990-2025)
Table: Key Population Ratios (Chile 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Chile 1990-2025)
Table: Population By Age Group (Chile 1990-2025)
Table: Population By Age Group % (Chile 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Chile Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Chile's economic and political stability in recent years has no doubt contributed to the stabilityof its clinical research landscape as R&D remains a prominent aspect of the country's largerpharmaceutical market. The country's recent shift toward patient access to high-value medicines throughthe Ricarte Soto Law will continue to encourage the development of clinical trials in Chile over the longterm.

Headline Expenditure Projections

Pharmaceuticals: From CLP2.4trn (USD3.7bn) in 2015 to CLP2.8trn (USD4.1bn) in 2016; +12.9% inlocal currency terms and +9.4% in US dollar terms. Forecast revised upwards from last quarter.

Healthcare: From CLP12.3trn (USD18.8bn) in 2015 to CLP13.3trn (USD19.7bn) in 2016; +8.1% rise inlocal currency terms and +4.8% in US dollar terms. Forecast revised upwards from last quarter.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;